Persona Biomed, Inc. (PBM) was incorporated in 2015 with the aim of accelerating the use of Precision Medicine molecular diagnostic healthcare practice with our development and commercialization of proprietary diagnostic and pharmaceutical laboratory technologies. Our technologies serve clinical physicians and the medical community at-large to improve patient outcomes.
Today Persona Biomed, Inc. is a clinical-stage global biotech company with a strong portfolio of know-how leveraging opportunities that cross technology synergies between molecular clinical biomarkers and target-oriented drug discovery.
PBM’s research has resulted in the award of one patent, the application of three more, acquiring various intellectual property trademarks and developing a portfolio of educational, laboratory and analytical technologies and commercial products and services.
PBM is transitioning from a cutting-edge Precision Medicine clinical research focused company to a commercialized medical technology products and services company.